BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16368152)

  • 1. The effect of Vitamin E treatment on the development of myringosclerosis after ventilation tube insertion.
    Uneri C; Bağlam T; Yazici M
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1045-8. PubMed ID: 16368152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin e treatment.
    Polat S; Oztürk O; Uneri C; Yüksel M; Haklar G; Bozkurt S; Küllü S
    Laryngoscope; 2004 Apr; 114(4):720-5. PubMed ID: 15064630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin e-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane.
    Uneri C; Sari M; Akboğa J; Yüksel M
    Laryngoscope; 2006 Jan; 116(1):140-3. PubMed ID: 16481827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-oxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis.
    Kazikdas KC; Uguz MZ; Erbil G; Tugyan K; Yilmaz O; Guneli E; Altun Z
    Otol Neurotol; 2006 Sep; 27(6):882-6. PubMed ID: 16788415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myringotomy versus ventilation tubes in secretory otitis media: eardrum pathology, hearing, and eustachian tube function 25 years after treatment.
    Cayé-Thomasen P; Stangerup SE; Jørgensen G; Drozdziewic D; Bonding P; Tos M
    Otol Neurotol; 2008 Aug; 29(5):649-57. PubMed ID: 18520632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the use of radiofrequency myringotomy for insertion of a ventilation tube reduce the incidence of myringosclerosis?
    Erdurak SC; Coskun BU; Sakalli E; Tansuker HD; Turan F; Kaya D
    Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):459-62. PubMed ID: 23494285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical investigation of inducible nitric oxide synthase, osteopontin, and calcium-sensing receptor in a myringosclerosis/tympanosclerosis model.
    Kucuktag Z; Satar B; Yetiser S; Hidir Y; Gunhan O
    Otol Neurotol; 2014 Jan; 35(1):e15-23. PubMed ID: 24136309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of topical adrenaline on the development of myringosclerosis after tympanostomy tube insertion.
    Banerjee AR; Jennings C; Marshall JN; Narula AA
    Am J Otol; 2000 Jul; 21(4):482-4. PubMed ID: 10912691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myringosclerosis after tympanostomy tube insertion: relation with tube retention time and gender.
    Yaman H; Guclu E; Yilmaz S; Ozturk O
    Auris Nasus Larynx; 2010 Dec; 37(6):676-9. PubMed ID: 20392579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy.
    Mattsson C; Stierna P; Hellström S
    Am J Otol; 2000 Nov; 21(6):804-8. PubMed ID: 11078067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspiration of middle ear effusions prior to grommet insertion an etiological factor in tympanosclerosis.
    McRae D; Gatland DJ; Youngs R; Cook J
    J Otolaryngol; 1989 Aug; 18(5):229-31. PubMed ID: 2769837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tympanometric changes in an experimental myringosclerosis model after myringotomy.
    Kazikdas KC; Serbetcioglu B; Boyraz I; Tugyan K; Erbil G; Yilmaz O; Onal K
    Otol Neurotol; 2006 Apr; 27(3):303-7. PubMed ID: 16639266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of topical doxycycline in the prevention of experimental tympanosclerosis.
    Ozcan I; Selcuk A; Ozcan KM; Akdogan O; Giray SG; Dere H; Ozogul C
    Laryngoscope; 2008 Jun; 118(6):1051-6. PubMed ID: 18388770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical application of calcium channel blockers to reduce the progression of experimentally induced myringosclerosis and tympanosclerosis.
    Selcuk A; Akdogan O; Ozcan I; Giray SG; Dere H; Ozogul C
    Laryngoscope; 2008 Apr; 118(4):697-705. PubMed ID: 18176349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for the appearance of myringosclerosis after myringotomy with ventilation tube placement: randomized study.
    Branco C; Monteiro D; Paço J
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):79-84. PubMed ID: 27395069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of experimental myringosclerosis in interpretation of tympanograms and its possible clinical implications.
    Cagdas KK
    Med Hypotheses; 2005; 64(6):1132-4. PubMed ID: 15823701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical mitomycin and trimetazidine on myringosclerosis.
    Cankaya H; Kösem M; Kiroglu F; Kiris M; Yuca K; Oztürk G; Dülger H; Erdogan E
    J Otolaryngol Head Neck Surg; 2008 Dec; 37(6):882-7. PubMed ID: 19128721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does passive smoking affect the outcome of grommet insertion in children?
    Praveen CV; Terry RM
    J Laryngol Otol; 2005 Jun; 119(6):448-54. PubMed ID: 15992470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis.
    Song JJ; Kwon SK; Cho CG; Park SW
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1287-91. PubMed ID: 17544518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of myringotomy with ventilation tube for otitis media with effusion in Thai children: Ramathibodi experiences.
    Tanpowpong K; Saisukul I; Kittimanont H; Rattanasiri S
    J Med Assoc Thai; 2007 Sep; 90(9):1866-71. PubMed ID: 17957932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.